ASML vs IBM
Leading supplier of advanced chip manufacturing equipment vs Global technology company powering hybrid cloud and AI. Which is the better buy for your portfolio in August 2026? Plain-English answer below.
ASML's monopoly on extreme ultraviolet lithography makes it the sole gatekeeper of advanced semiconductor manufacturing, while IBM has spent years repositioning itself as a hybrid cloud and AI services provider after decades as a hardware giant. Both companies generate significant free cash flow and maintain strong competitive positions within their respective technology niches. The ASML vs IBM comparison examines how a hardware monopoly with constrained capacity differs from a services-led transformation story when it comes to revenue growth durability, margin expansion potential, and shareholder return mechanics.
ASML's monopoly on extreme ultraviolet lithography makes it the sole gatekeeper of advanced semiconductor manufacturing, while IBM has spent years repositioning itself as a hybrid cloud and AI service...
Why It’s Moving
ASML stays near highs, but analyst caution is keeping downside risk in focus.
- ASML’s latest quarterly update and raised 2026 outlook are still driving sentiment, as investors parse how AI-related chip demand is supporting demand for EUV systems and higher full-year revenue expectations.
- Analyst commentary over the past week has stayed mixed but mostly constructive, with some firms reiterating buy-leaning views while at least one downgrade and cautious note have kept downside concerns in focus.
- The stock has been trading near record territory, so even positive guidance has increasingly translated into valuation sensitivity, making shares more vulnerable to any sign of slower equipment demand or softer 2026 growth.
- Broader semiconductor equipment momentum remains tied to AI infrastructure spending, which is helping the group overall but also raising expectations that leave less room for disappointment.
IBM stays in focus as earnings disappointment, guidance cuts, and legal scrutiny keep pressure on shares.
- A recent Q2 earnings reset still hangs over the stock, with revenue missing expectations and management trimming full-year guidance, signaling that IBM’s growth story is taking longer to prove out.
- Investors are also weighing a fresh quantum-computing milestone against concerns that the company’s core software and infrastructure mix is producing uneven results, keeping sentiment mixed.
- A new securities-law investigation added another layer of caution after the sharp July selloff, increasing attention on execution and disclosure rather than near-term upside.
ASML stays near highs, but analyst caution is keeping downside risk in focus.
- ASML’s latest quarterly update and raised 2026 outlook are still driving sentiment, as investors parse how AI-related chip demand is supporting demand for EUV systems and higher full-year revenue expectations.
- Analyst commentary over the past week has stayed mixed but mostly constructive, with some firms reiterating buy-leaning views while at least one downgrade and cautious note have kept downside concerns in focus.
- The stock has been trading near record territory, so even positive guidance has increasingly translated into valuation sensitivity, making shares more vulnerable to any sign of slower equipment demand or softer 2026 growth.
- Broader semiconductor equipment momentum remains tied to AI infrastructure spending, which is helping the group overall but also raising expectations that leave less room for disappointment.
IBM stays in focus as earnings disappointment, guidance cuts, and legal scrutiny keep pressure on shares.
- A recent Q2 earnings reset still hangs over the stock, with revenue missing expectations and management trimming full-year guidance, signaling that IBM’s growth story is taking longer to prove out.
- Investors are also weighing a fresh quantum-computing milestone against concerns that the company’s core software and infrastructure mix is producing uneven results, keeping sentiment mixed.
- A new securities-law investigation added another layer of caution after the sharp July selloff, increasing attention on execution and disclosure rather than near-term upside.
Investment Analysis
ASML
ASML
Pros
- ASML holds a dominant market position as the sole supplier of advanced extreme ultraviolet (EUV) lithography machines critical for semiconductor manufacturing.
- The company has demonstrated strong revenue growth, reaching nearly $30 billion, driven by high demand for next-generation chip production.
- ASML exhibits a high return on equity (around 54%), reflecting efficient capital use and strong profitability relative to its peers.
Considerations
- ASML's valuation metrics, such as a high price-to-book ratio, suggest investors are paying a premium that depends on continued technological leadership and market growth.
- Revenue growth expectations show volatility, with very low growth anticipated in 2024 before a strong rebound, indicating potential exposure to semiconductor industry cyclicality.
- The company operates in a highly specialized, capital-intensive industry with execution risks related to complex technology development and geopolitical supply chain sensitivities.
IBM
IBM
Pros
- IBM is strategically pivoting towards high-margin sectors like cloud computing and artificial intelligence, aiming for future revenue and earnings growth.
- Despite recent revenue decline, IBM maintains a solid profitability profile with a return on equity near 29%, indicating effective capital deployment.
- The company benefits from its established market presence and diverse IT services portfolio, supporting steady cash flow and operational stability.
Considerations
- IBM’s revenue has declined due to divestitures and transition efforts, reflecting challenges in sustaining top-line growth during its strategic turnaround.
- Profit margins are lower compared to ASML, suggesting IBM faces higher costs or pricing pressures which may limit near-term profitability expansion.
- Growth forecasts for IBM are modest, with low to mid-single digit revenue and earnings growth expected over the next few years, reflecting its mature market status.
next-earnings-date-heading
The next earnings date for ASML is expected on October 14, 2026. It should cover Q3 2026 results. ASML’s recent reporting pattern also supports that timing, with the prior quarter reported on July 15, 2026.
next-earnings-date-heading
IBM’s next earnings date is expected on October 21, 2026, based on its current preliminary schedule. The report will cover third-quarter 2026 results. IBM has not yet formally confirmed the date, so it should be treated as the expected announcement timing rather than a finalized release date.
next-earnings-date-heading
The next earnings date for ASML is expected on October 14, 2026. It should cover Q3 2026 results. ASML’s recent reporting pattern also supports that timing, with the prior quarter reported on July 15, 2026.
next-earnings-date-heading
IBM’s next earnings date is expected on October 21, 2026, based on its current preliminary schedule. The report will cover third-quarter 2026 results. IBM has not yet formally confirmed the date, so it should be treated as the expected announcement timing rather than a finalized release date.
Buy ASML or IBM in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
